Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.
Learn More
At ASM Microbe, Attention on Reimbursement and Drug-Resistant Pathogens
Luminex workshop offered a look at flexible molecular testing for GI cases
We’re finally recovering from the whirlwind that is ASM Microbe, the annual mega-conference of the American Society for Microbiology. This year, the event took place in sunny San Francisco, bringing thousands of microbial experts together to discuss the latest advances and challenges in this field.
Continue Reading >
Dr. Gonzalez is a family practitioner who treats an eclectic mix of patients, young and old. He runs a smart practice and knows the value of syndromic testing as well as when a targeted approach makes better sense, especially when testing for a potential respiratory illness. Watch how he works to strategically treat two types of patients with respiratory infections.
Watch more videos >
July 1
Luminex Submits ARIES MRSA Assay for FDA Clearance
May 21
Luminex Corporation Declares Second Quarter Cash Dividend
May 14
Luminex Corporation to Present at Upcoming Healthcare Investor Conferences
May 6
Luminex Corporation Reports First Quarter 2019 Financial Results
April 18
Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019
AACC Annual Meeting & Clinical Lab Expo
August 6-8
Anaheim, CA
IDWeek
October 2-6
Washington, D.C.
xMAP® Connect San Diego
October 3
San Diego, CA
